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Identity 
Mesothelioma is an aggressive tumor derived from 
mesothelial cells. It is primarily found in the pleura 
(75%), peritoneum (10-20%), pericardium (1%) and 
tunica vaginalis (< 1%) (Moore et al., 2008). 
Mesothelioma is strongly associated with exposure 
to asbestos which can be documented in about 50-
80% of pleural cases and 30% of peritoneal 
mesothelioma in men (Bianchi and Bianchi, 2007). 
Genetic predisposition, smoking, radiation, and 
viral infection can also contribute to mesothelioma. 
The onset of mesothelioma is insidious with a 
latency of 30 years (range: 20 to 50 years).  
The mean age of the patients is 60 years, but the 
disease can occur at any age (Moore et al., 2008). 
Survival rates vary but they generally remain low 
(Asbestos.com). 
Clinics and pathology 
Disease 
Mesothelioma 
Phenotype / cell stem origin 
Mesothelioma is derived from mesothelial cells. 
Embryonic origin 
Unknown. 
Etiology 
Mesothelioma is strongly associated with exposure 
to asbestos which can be documented in about 50-
80% of pleural cases and 30% of peritoneal 
mesothelioma in men (Bianchi and Bianchi, 2007).  
Genetic predisposition, smoking, radiation, and 
viral infection can also contribute to mesothelioma 
either alone or together with exposure to asbestos. 
Epidemiology 
For a detailed and update epidemiology of 
mesothelioma see: 
http://www.uptodate.com/contents/epidemiology-
of-malignant-pleural-mesothelioma. 
Genetics 
Note 
Abnormal karyotypes detected by cytogenetic 
analysis have been reported in 128 mesotheliomas 
(Mitelman database).  
The changes are mostly complex, but a number of 
nonrandom abnormalities have been found 
involving chromosome arms 1p, 3p, 6q, 9p, and 
22q. Studies using comparative genomic 
hybridization, loss of heterozygosity, and 
fluorescence in situ hybridization (FISH) have also 
shown repeated regional chromosomal gains and 
losses. Among them, losses of chromosome bands 
14q32 and 22q12 were found in 43-50% and 36% 
of the cases, respectively (Taniguchi et al., 2007; 
Takeda et al., 2012). On band 22q12, the NF2 gene 
was found to be mutated in 40% of mesotheliomas 
leading to complete functional inactivation of NF2 
(see Thurneysen et al., 2009; and references 
therein). In two other studies, NF2 was found to be 
deleted (Taniguchi et al., 2007; Takeda et al., 
2012). On chromosome band 14q32, the CHGA 
and ITPK1 genes were found to be deleted 
(Taniguchi et al., 2007; Takeda et al., 2012). 
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A. Fluorescence in situ hybridization using BAC RP11-638I2 (FITC, green) for the YY1 gene (14q32) and RP11-612D3 (Texas 
Red, red) for the EWSR1 gene (22q12). The fusion signals are seen on both derivative chromosomes. B. Mapping position of the 
RP11-638I2. C. Mapping position of the RP11-612D3. 
 
 
Cytogenetics 
Note 
In a mesothelioma, which was diagnosed as 
epithelioid type, the G-banding analysis yielded a 
karyotype with only a single chromosomal 
abnormality: 
46,XY,t(14;22)(q32;q12)[10]/46,XY[5] 
(Panagopoulos et al., 2013). 
 
Partial karyotype showing the two derivative chromosomes, 
der(14)t(14;22)(q22;q12) and der(22)t(14;22)(q22;q12), 
from the 14;22 translocation together with their 
corresponding normal homologues; breakpoints are 
indicated by arrows. 
Genes involved and 
proteins 
YY1 
Location 
14q32.2 
DNA / RNA 
Spans 44.495 kb on plus strand. 
 
 
 
 
Protein 
414 amino acids, 44.7 kDa. 
EWSR1 
Location 
22q12.2 
DNA / RNA 
Spans 32.5 kb on plus strand. Transcript of 2654 bp 
from 17 exons for the canonical form, with a coding 
sequence of 1971 nt. 
Protein 
656 amino acids, 68.5 kDa. 
Result of the chromosomal 
anomaly 
Hybrid Gene 
Note 
The balanced 14;22-translocation generates a 
functional EWSR1-YY1 chimeric gene in which 
exon 8 of EWSR1 (nucleotide 1139 accession 
number NM_013986 version 3; former exon 7 in 
sequence with accession number X66899) is fused 
to exon 2 of YY1 (nucleotide 1160 accession 
number NM_003403 version 3). The putative 
EWSR1-YY1 protein would contain the 
transactivation domain of EWSR1 and the DNA 
binding domain of YY1 and thus may act as an 
abnormal transcription factor. 
Description 
The EWSR1-YY1 fusion gene was detected in 2 so 
far mesotheliomas (Panagopoulos et al., 2013). 
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Partial sequence chromatogram showing the fusion of exon 8 of EWSR1 with exon 2 of YY1. 
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